Abbott Laboratories(ABT)
106.59
Change: -1.38 (▼ -1.29%)
As of Tue 12/20/2022 08:40 AM% Of Value
Growth
Value Per Share
:
:
:
605.12
24.47
29.7000 (as of 19/12/2022)
Fundamentals Data
| Open | 106.74 | Dividend | 1483 |
| Close Price | 106.59 | DivYield | 2.55 % |
| High | 107.18 | Growth | 8.4 B |
| Low | 105.83 | Growth% | 24.47 |
| P/e | 56.47 | Volume | 4.3 M |
| P/b | 1.51 | Market Capital | 188.8 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 102.82 (as of 20/12/2022) | 50 Days Moving Average Percentage | 5.2534095097678 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 27.3 B | 30.5 B | 31.9 B | 34.6 B | 43.0 B |
| Cap Spending | -1.1 B | -1.3 B | -1.6 B | -2.1 B | -1.8 B |
| Operating Expenses | 13.3 B | 14.2 B | 14.1 B | 14.2 B | 16.1 B |
| Operating Cash Flow | 1.7 B | 3.6 B | 4.5 B | 5.3 B | 8.4 B |
| Free Cash Flow | 4.4 B | 4.9 B | 4.4 B | 5.7 B | 8.6 B |
| Free Cash Flow Per Share | 2.549 | 2.791 | 2.544 | 3.228 | 4.872 |
| Total liabilities | 27.9 B | 19.5 B | 18.1 B | 18.7 B | 18.0 B |
| Total cash | 9.6 B | 4.0 B | 4.1 B | 7.1 B | 10.2 B |
| ROE% | 0.015 | 0.076 | 0.117 | 0.143 | 0.204 |
| Outstanding Shares | 1.7 B | 1.7 B | 1.7 B | 1.7 B | 1.7 B |
| P/E | 220.287 | 56.47 | 41.826 | 48.491 | 29.127 |
| P/S | 3.836 | 4.373 | 4.834 | 6.298 | 4.781 |
| Revenue USD | 27.3 B | 30.5 B | 31.9 B | 34.6 B | 43.0 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|